SC 13G Filing

Company

ALNYLAM PHARMACEUTICALS, INC.

Filed

June 4, 2010

Accession Number

0001408408-10-000004

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →